CANADIAN IMMUNO-ONCOLOGY 2022 HYBRID CONFERENCE
The Canadian Immuno-Oncology Conference 2022 is a one-day hybrid event (in-person & digital) held in Eastern Standard Time. The meeting will cover a variety of important topics examining advances in immuno-oncology and will also explore topics that pertain to clinical practice, adverse event management and the pharmacoeconomics of novel therapies.
Friday, September 30, 2022
Join Us Live In Person
at the
BMO Institute for Learning, Toronto
Registration for Healthcare professionals can be completed below. Industry representatives (both sponsor and non-sponsor) must contact Kelly Allan at kelly@oncologyeducation.ca for registration and sponsorship opportunities.
Buy Tickets
In Person & Virtual Options Below:
Scientific Agenda
Times listed are EST
7:00am – 8:00am
Registration and Breakfast Buffet
8:00am – 8:15am
Welcome Address by Chairs – Dr. Parneet Cheema & Dr. Michael Smylie
8:15am – 9:00am
Breakfast Symposium: TBA
9:00am – 9:45am
Immunotherapy – Dr. Jason Luke
9:45am – 10:10am
GI Updates
10:10am – 10:30am
Networking Break & Sponsor Exhibits
10:30am – 10:55am
Cardiac Toxicity – Dr. Paaladinesh Thavendiranathan
10:55am – 11:20am
Dermatologic Toxicities – Dr. Tom Salopek
11:20am – 11:45am
Breast Cancer – Dr. Dave Cescon
11:45am – 12:10pm
Lung Cancer – Dr. Natasha Leighl
12:10pm – 12:40pm
Lunch Break
12:40pm – 1:25pm
AstraZeneca Lunch Symposium: TBA
1:25pm – 1:50pm
Genitourinary (GU) – Dr. Christian Kollmansberger
1:50pm – 2:15pm
TBA
2:15pm – 2:35pm
Networking Break & Sponsor Exhibits
2:35pm – 3:00pm
Biomarkers – Dr. Anna Spreafico
3:00pm – 3:25pm
Drug Development Beyond PD1 and CTLA4
3:25pm – 3:40pm
Closing Remarks by Chairs – Dr. Parneet Cheema & Dr. Michael Smylie
About the Faculty
Dr. Parneet Cheema
Conference Chair
Dr. Parneet Cheema is an Assistant Professor at the University of Toronto and Medical Oncologist at the William Osler Health System with a focus in thoracic, and skin malignancies. Dr. Cheema completed her undergraduate medical training at the University of Calgary, followed by Internal Medicine, and Medical Oncology training at the University of Toronto. Dr. Cheema also completed a Master’s degree in Biotechnology from the University of Toronto. She is the Head of Cancer Research at William Osler Health System and has been principle investigator and on global steering committees for clinical trials in the areas of melanoma and NSCLC using immunotherapies and targeted therapy. She began the Osler Immunotherapy for Cancer Program that focuses on management of immune related adverse events and patient education.
Dr. Michael Smylie
Conference Chair
Dr. Michael Smylie is Medical Oncologist at the Cross Cancer Institute in Edmonton, Alberta.
He holds an academic appointment as Professor, Department of Oncology, University of Alberta, Edmonton.
Dr. Michael Smylie is the past Site Leader for the Clinical Trials Committee, Cross Cancer Institute and past leader of the National Canada Institute of Cancer (NCIC) melanoma group.
Dr. Smylie has chaired several National Melanoma meetings and is the past chair of the Canadian Melanoma Conference.
Sponsorship
PLATINUM
GOLD
SILVER
